Literature DB >> 7834256

Maintenance ECT in intractable manic-depressive disorders.

J M Vanelle1, H Loo, A Galinowski, W de Carvalho, M C Bourdel, P Brochier, O Bouvet, T Brochier, J P Olie.   

Abstract

Twenty-two patients suffering from intractable recurrent unipolar or bipolar mood disorders were enrolled in a maintenance-ECT protocol (ECT-M) for more than 18 months, with a treatment at approximately monthly intervals. Eleven have continued treatment for > 2 years. Whereas 44% of the year had been spent in the hospital with at least three episodes a year prior to ECT-M, only 7% of the year was spent in the hospital during ECT-M with only one relapse every 16 months requiring admission (p < 0.001). Forty-five percent of the patients were in full remission and 27% in partial remission according to DSM-III-R criteria. ECT-M responsiveness of rapid-cyclers and delusional depressed patients usually drug refractory has been very encouraging with full or partial remission for 100% of rapid-cyclers and 80% of delusional depressed patients.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7834256

Source DB:  PubMed          Journal:  Convuls Ther        ISSN: 0749-8055


  9 in total

1.  A review of bipolar disorder in adults.

Authors:  Donald M Hilty; Martin H Leamon; Russell F Lim; Rosemary H Kelly; Robert E Hales
Journal:  Psychiatry (Edgmont)       Date:  2006-09

2.  Diagnostic and therapeutic advances in treatment-resistant mood disorders.

Authors:  B J Blinder; A R Bloom
Journal:  West J Med       Date:  1996-03

Review 3.  Emerging options in the treatment of bipolar disorders.

Authors:  M Berk; J Segal; L Janet; M Vorster
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 4.  Current concepts in rapid cycling bipolar disorder.

Authors:  M D Shelton; J R Calabrese
Journal:  Curr Psychiatry Rep       Date:  2000-08       Impact factor: 5.285

Review 5.  Electroconvulsive Therapy in Psychiatric Disorders: A Narrative Review Exploring Neuroendocrine-Immune Therapeutic Mechanisms and Clinical Implications.

Authors:  Milagros Rojas; Daniela Ariza; Ángel Ortega; Manuel E Riaño-Garzón; Mervin Chávez-Castillo; José Luis Pérez; Lorena Cudris-Torres; María Judith Bautista; Oscar Medina-Ortiz; Joselyn Rojas-Quintero; Valmore Bermúdez
Journal:  Int J Mol Sci       Date:  2022-06-22       Impact factor: 6.208

Review 6.  [Electroconvulsive therapy as maintenance therapy and for prevention of recurrence in psychiatric disorders and Parkinson disease].

Authors:  Matthäus Willeit; Nicole Praschak-Rieder; Siegfried Kasper
Journal:  Wien Klin Wochenschr       Date:  2003-05-15       Impact factor: 1.704

7.  The Role of Electroconvulsive Therapy (ECT) in Bipolar Disorder: Effectiveness in 522 Patients with Bipolar Depression, Mixed-state, Mania and Catatonic Features.

Authors:  Giulio Perugi; Pierpaolo Medda; Cristina Toni; Michela Giorgi Mariani; Chiara Socci; Mauro Mauri
Journal:  Curr Neuropharmacol       Date:  2017-04       Impact factor: 7.363

8.  The CINP Guidelines on the Definition and Evidence-Based Interventions for Treatment-Resistant Bipolar Disorder.

Authors:  Konstantinos N Fountoulakis; Lakshmi N Yatham; Heinz Grunze; Eduard Vieta; Allan H Young; Pierre Blier; Mauricio Tohen; Siegfried Kasper; Hans Jurgen Moeller
Journal:  Int J Neuropsychopharmacol       Date:  2020-04-23       Impact factor: 5.176

9.  Electroconvulsive Therapy (ECT) in Bipolar Disorder Patients with Ultra-Rapid Cycling and Unstable Mixed States.

Authors:  Sergey Mosolov; Christoph Born; Heinz Grunze
Journal:  Medicina (Kaunas)       Date:  2021-06-15       Impact factor: 2.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.